|
Volumn 28, Issue 11 Suppl, 2005, Pages 58-66
|
New perspectives in the medical treatment of acromegaly.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DOPAMINE RECEPTOR STIMULATING AGENT;
DRUG DERIVATIVE;
GROWTH HORMONE RECEPTOR;
HUMAN GROWTH HORMONE;
OCTREOTIDE;
PASIREOTIDE;
PEGVISOMANT;
SOM-230;
SOMATOMEDIN C;
SOMATOSTATIN;
SOMATOSTATIN RECEPTOR;
ACROMEGALY;
ADENOMA;
ADULT;
ANIMAL;
COMPARATIVE STUDY;
DELAYED RELEASE FORMULATION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG POTENTIATION;
FEMALE;
HUMAN;
HYPOPHYSIS TUMOR;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
REVIEW;
ACROMEGALY;
ADENOMA;
ADULT;
ANIMALS;
DELAYED-ACTION PREPARATIONS;
DOPAMINE AGONISTS;
FEMALE;
HUMAN GROWTH HORMONE;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
MALE;
MIDDLE AGED;
OCTREOTIDE;
PITUITARY NEOPLASMS;
RECEPTORS, SOMATOSTATIN;
RECEPTORS, SOMATOTROPIN;
SOMATOSTATIN;
|
EID: 33744994123
PISSN: 03914097
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (6)
|
References (66)
|